|
GB9919413D0
(en)
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
AU7962200A
(en)
*
|
1999-10-29 |
2001-05-14 |
Wakunaga Pharmaceutical Co., Ltd |
Novel indole derivatives and drugs containing the same as the active ingredient
|
|
BR0208956A
(pt)
*
|
2001-04-16 |
2004-07-13 |
Tanabe Seiyaku Co |
Abridor de canais de k ativados por cálcio de grande condutância
|
|
CN1330641C
(zh)
|
2001-08-10 |
2007-08-08 |
日本化学医药株式会社 |
过氧化物酶体增殖剂响应受体δ活化剂
|
|
PT1445258E
(pt)
|
2001-10-12 |
2009-07-02 |
Nippon Chemiphar Co |
Activador para o receptor delta activado por proliferador de peroxissoma
|
|
KR20070083484A
(ko)
*
|
2004-07-14 |
2007-08-24 |
피티씨 테라퓨틱스, 인크. |
Ｃ형 간염 치료 방법
|
|
NZ554491A
(en)
*
|
2004-10-12 |
2009-07-31 |
Decode Genetics Ehf |
Sulfonamide peri-substituted bicyclics for occlusive artery disease
|
|
WO2006046683A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Astellas Pharma Inc. |
Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
|
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
GB2431927B
(en)
*
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
CN101460458A
(zh)
*
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
KR20080102181A
(ko)
*
|
2006-02-15 |
2008-11-24 |
알러간, 인코포레이티드 |
스핑고신-1-포스페이트 (에스1피) 수용체 길항제 생물학적 활성을 갖는 아릴 또는 헤테로아릴기를 포함하는 인돌-3-카르보실산 아미드, 에스테르, 티오아미드 및 티올 에스테르 화합물
|
|
ZA200809148B
(en)
|
2006-04-18 |
2010-01-27 |
Nippon Chemiphar Co |
Activating agent for peroxisome proliferator activated receptor delta
|
|
DE102006021733A1
(de)
*
|
2006-05-09 |
2007-11-22 |
Bayer Healthcare Ag |
3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
|
|
EP2027117A2
(en)
*
|
2006-05-16 |
2009-02-25 |
Decode Genetics EHF |
Process for preparing 7-(acryloyl)-indoles
|
|
DE102006043443A1
(de)
*
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Neue aza-bicyclische Verbindungen und ihre Verwendung
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
WO2008089015A1
(en)
|
2007-01-11 |
2008-07-24 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
|
AU2009236877B2
(en)
|
2008-04-15 |
2014-01-23 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-activated receptor
|
|
US8546431B2
(en)
|
2008-10-01 |
2013-10-01 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
KR101512548B1
(ko)
|
2010-03-12 |
2015-04-15 |
오메로스 코포레이션 |
Pde10 억제제 및 관련 조성물 및 방법
|
|
JP5918264B2
(ja)
|
2010-12-22 |
2016-05-18 |
アッヴィ・インコーポレイテッド |
Ｃ型肝炎阻害剤およびその使用
|
|
JP6386478B2
(ja)
|
2013-02-21 |
2018-09-05 |
アドヴェリオ・ファーマ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
メチル｛４，６−ジアミノ−２−［１−（２−フルオロベンジル）−１ｈ−ピラゾロ［３，４−ｂ］ピリジノ−３−イル］ピリミジノ−５−イル｝メチルカルバメートの形態
|
|
NZ630803A
(en)
|
2014-04-28 |
2016-03-31 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
NZ716494A
(en)
|
2014-04-28 |
2017-07-28 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
CN107108534B
(zh)
|
2014-08-29 |
2023-05-09 |
Chdi基金会股份有限公司 |
用于成像亨廷顿蛋白的探针
|
|
AU2016250843A1
(en)
|
2015-04-24 |
2017-10-12 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
WO2017079678A1
(en)
|
2015-11-04 |
2017-05-11 |
Omeros Corporation |
Solid state forms of a pde10 inhibitor
|
|
CN111372576A
(zh)
|
2017-11-17 |
2020-07-03 |
塞尔利克斯生物私人有限公司 |
用于治疗眼部病症的组合物和方法
|